Resection as first-line therapy for large hepatic sclerosing hemangioma: a case report

Abstract

Li Xu, Xu Yang, Shan Ke, Xue-mei Ding, Shao-hong Wang, Jun Gao, Wen-bing SunDepartment of Hepatobiliary Surgery, Beijing Chao-yang Hospital Affiliated with Capital Medical University, Beijing 100043, People’s Republic of ChinaCorrespondence: Jun Gao; Wen-bing SunDepartment of Hepatobiliary Surgery, Beijing Chao-yang Hospital Affiliated with Capital Medical University, No. 5 Jingyuan Street, Beijing 100043, People’s Republic of ChinaFax [phone]Email [email protected] [email protected]: Hepatic sclerosing hemangioma is a rare benign disease that occurs in association with hepatic cavernous hemangioma degeneration and sclerosis. Recent studies have shown that radiofrequency (RF) ablation is an alternative treatment for hepatic cavernous hemangiomas, even for large hemangiomas (≥10 cm). However, RF ablation might not be suitable to treat large sclerosing hemangiomas. We herein report the successful surgical removal of a large hepatic sclerosing hemangioma after RF ablation treatment failure in a 65-year-old man. In conclusion, we suggest that resection should be chosen as a first-line therapy for the disease.Keywords: resection, radiofrequency ablation, hepatic cavernous hemangiomas, hepatic sclerosing hemangioma

Keywords

• Resection
• Radiofrequency ablation
• Hepatic cavernous hemangiomas
• Hepatic sclerosed hemangioma